Cargando…

The small molecule CA140 inhibits the neuroinflammatory response in wild-type mice and a mouse model of AD

BACKGROUND: Neuroinflammation is associated with neurodegenerative diseases, including Alzheimer’s disease (AD). Thus, modulating the neuroinflammatory response represents a potential therapeutic strategy for treating neurodegenerative diseases. Several recent studies have shown that dopamine (DA) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ju-Young, Nam, Jin Han, Nam, Youngpyo, Nam, Hye Yeon, Yoon, Gwangho, Ko, Eunhwa, Kim, Sang-Bum, Bautista, Mahealani R, Capule, Christina C, Koyanagi, Takaoki, Leriche, Geoffray, Choi, Hwan Geun, Yang, Jerry, Kim, Jeongyeon, Hoe, Hyang-Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182807/
https://www.ncbi.nlm.nih.gov/pubmed/30309372
http://dx.doi.org/10.1186/s12974-018-1321-3
_version_ 1783362650061668352
author Lee, Ju-Young
Nam, Jin Han
Nam, Youngpyo
Nam, Hye Yeon
Yoon, Gwangho
Ko, Eunhwa
Kim, Sang-Bum
Bautista, Mahealani R
Capule, Christina C
Koyanagi, Takaoki
Leriche, Geoffray
Choi, Hwan Geun
Yang, Jerry
Kim, Jeongyeon
Hoe, Hyang-Sook
author_facet Lee, Ju-Young
Nam, Jin Han
Nam, Youngpyo
Nam, Hye Yeon
Yoon, Gwangho
Ko, Eunhwa
Kim, Sang-Bum
Bautista, Mahealani R
Capule, Christina C
Koyanagi, Takaoki
Leriche, Geoffray
Choi, Hwan Geun
Yang, Jerry
Kim, Jeongyeon
Hoe, Hyang-Sook
author_sort Lee, Ju-Young
collection PubMed
description BACKGROUND: Neuroinflammation is associated with neurodegenerative diseases, including Alzheimer’s disease (AD). Thus, modulating the neuroinflammatory response represents a potential therapeutic strategy for treating neurodegenerative diseases. Several recent studies have shown that dopamine (DA) and its receptors are expressed in immune cells and are involved in the neuroinflammatory response. Thus, we recently developed and synthesized a non-self-polymerizing analog of DA (CA140) and examined the effect of CA140 on neuroinflammation. METHODS: To determine the effects of CA140 on the neuroinflammatory response, BV2 microglial cells were pretreated with lipopolysaccharide (LPS, 1 μg/mL), followed by treatment with CA140 (10 μM) and analysis by reverse transcription-polymerase chain reaction (RT-PCR). To examine whether CA140 alters the neuroinflammatory response in vivo, wild-type mice were injected with both LPS (10 mg/kg, intraperitoneally (i.p.)) and CA140 (30 mg/kg, i.p.), and immunohistochemistry was performed. In addition, familial AD (5xFAD) mice were injected with CA140 or vehicle daily for 2 weeks and examined for microglial and astrocyte activation. RESULTS: Pre- or post-treatment with CA140 differentially regulated proinflammatory responses in LPS-stimulated microglia and astrocytes. Interestingly, CA140 regulated D1R levels to alter LPS-induced proinflammatory responses. CA140 significantly downregulated LPS-induced phosphorylation of ERK and STAT3 in BV2 microglia cells. In addition, CA140-injected wild-type mice exhibited significantly decreased LPS-induced microglial and astrocyte activation. Moreover, CA140-injected 5xFAD mice exhibited significantly reduced microglial and astrocyte activation. CONCLUSIONS: CA140 may be beneficial for preventing and treating neuroinflammatory-related diseases, including AD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12974-018-1321-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6182807
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61828072018-10-18 The small molecule CA140 inhibits the neuroinflammatory response in wild-type mice and a mouse model of AD Lee, Ju-Young Nam, Jin Han Nam, Youngpyo Nam, Hye Yeon Yoon, Gwangho Ko, Eunhwa Kim, Sang-Bum Bautista, Mahealani R Capule, Christina C Koyanagi, Takaoki Leriche, Geoffray Choi, Hwan Geun Yang, Jerry Kim, Jeongyeon Hoe, Hyang-Sook J Neuroinflammation Research BACKGROUND: Neuroinflammation is associated with neurodegenerative diseases, including Alzheimer’s disease (AD). Thus, modulating the neuroinflammatory response represents a potential therapeutic strategy for treating neurodegenerative diseases. Several recent studies have shown that dopamine (DA) and its receptors are expressed in immune cells and are involved in the neuroinflammatory response. Thus, we recently developed and synthesized a non-self-polymerizing analog of DA (CA140) and examined the effect of CA140 on neuroinflammation. METHODS: To determine the effects of CA140 on the neuroinflammatory response, BV2 microglial cells were pretreated with lipopolysaccharide (LPS, 1 μg/mL), followed by treatment with CA140 (10 μM) and analysis by reverse transcription-polymerase chain reaction (RT-PCR). To examine whether CA140 alters the neuroinflammatory response in vivo, wild-type mice were injected with both LPS (10 mg/kg, intraperitoneally (i.p.)) and CA140 (30 mg/kg, i.p.), and immunohistochemistry was performed. In addition, familial AD (5xFAD) mice were injected with CA140 or vehicle daily for 2 weeks and examined for microglial and astrocyte activation. RESULTS: Pre- or post-treatment with CA140 differentially regulated proinflammatory responses in LPS-stimulated microglia and astrocytes. Interestingly, CA140 regulated D1R levels to alter LPS-induced proinflammatory responses. CA140 significantly downregulated LPS-induced phosphorylation of ERK and STAT3 in BV2 microglia cells. In addition, CA140-injected wild-type mice exhibited significantly decreased LPS-induced microglial and astrocyte activation. Moreover, CA140-injected 5xFAD mice exhibited significantly reduced microglial and astrocyte activation. CONCLUSIONS: CA140 may be beneficial for preventing and treating neuroinflammatory-related diseases, including AD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12974-018-1321-3) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-11 /pmc/articles/PMC6182807/ /pubmed/30309372 http://dx.doi.org/10.1186/s12974-018-1321-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Lee, Ju-Young
Nam, Jin Han
Nam, Youngpyo
Nam, Hye Yeon
Yoon, Gwangho
Ko, Eunhwa
Kim, Sang-Bum
Bautista, Mahealani R
Capule, Christina C
Koyanagi, Takaoki
Leriche, Geoffray
Choi, Hwan Geun
Yang, Jerry
Kim, Jeongyeon
Hoe, Hyang-Sook
The small molecule CA140 inhibits the neuroinflammatory response in wild-type mice and a mouse model of AD
title The small molecule CA140 inhibits the neuroinflammatory response in wild-type mice and a mouse model of AD
title_full The small molecule CA140 inhibits the neuroinflammatory response in wild-type mice and a mouse model of AD
title_fullStr The small molecule CA140 inhibits the neuroinflammatory response in wild-type mice and a mouse model of AD
title_full_unstemmed The small molecule CA140 inhibits the neuroinflammatory response in wild-type mice and a mouse model of AD
title_short The small molecule CA140 inhibits the neuroinflammatory response in wild-type mice and a mouse model of AD
title_sort small molecule ca140 inhibits the neuroinflammatory response in wild-type mice and a mouse model of ad
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182807/
https://www.ncbi.nlm.nih.gov/pubmed/30309372
http://dx.doi.org/10.1186/s12974-018-1321-3
work_keys_str_mv AT leejuyoung thesmallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT namjinhan thesmallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT namyoungpyo thesmallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT namhyeyeon thesmallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT yoongwangho thesmallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT koeunhwa thesmallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT kimsangbum thesmallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT bautistamahealanir thesmallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT capulechristinac thesmallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT koyanagitakaoki thesmallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT lerichegeoffray thesmallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT choihwangeun thesmallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT yangjerry thesmallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT kimjeongyeon thesmallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT hoehyangsook thesmallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT leejuyoung smallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT namjinhan smallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT namyoungpyo smallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT namhyeyeon smallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT yoongwangho smallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT koeunhwa smallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT kimsangbum smallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT bautistamahealanir smallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT capulechristinac smallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT koyanagitakaoki smallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT lerichegeoffray smallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT choihwangeun smallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT yangjerry smallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT kimjeongyeon smallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad
AT hoehyangsook smallmoleculeca140inhibitstheneuroinflammatoryresponseinwildtypemiceandamousemodelofad